Duquesne Family Office LLC / SLN
Duquesne Family Office LLC’s Silence Therapeutics PLC Position
Does Duquesne Family Office LLC own Silence Therapeutics PLC (SLN)? Not currently — the last reported position was 387.4K shares worth $7M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$7M
Q3 2024
Shares
387.4K
% of Portfolio
+0.24%
Quarters Held
3
position exited
Position History SLN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of SLN.